ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $40,025,000 | -29.4% | 990,262 | +0.5% | 0.04% | -18.5% |
| Q2 2015 | $56,723,000 | -2.5% | 985,631 | +7.8% | 0.05% | -3.6% |
| Q1 2015 | $58,193,000 | +25.5% | 913,980 | +21.7% | 0.06% | +27.3% |
| Q4 2014 | $46,360,000 | +50.8% | 750,897 | -5.2% | 0.04% | +46.7% |
| Q3 2014 | $30,742,000 | +17.7% | 791,697 | +4.4% | 0.03% | +15.4% |
| Q2 2014 | $26,113,000 | +44.6% | 757,997 | +81.3% | 0.03% | +36.8% |
| Q1 2014 | $18,062,000 | +26.9% | 417,997 | +17.0% | 0.02% | +18.8% |
| Q4 2013 | $14,231,000 | +64.6% | 357,197 | +55.1% | 0.02% | +45.5% |
| Q3 2013 | $8,648,000 | +550.2% | 230,357 | +365.4% | 0.01% | +450.0% |
| Q2 2013 | $1,330,000 | – | 49,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
| DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
| WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
| Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
| Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
| Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
| PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
| Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
| Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |